Education
About Us
Working with TipRanks
Follow Us
Vistin Pharma ASA (DE:VP4)
BERLIN:VP4
VP4 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€1.72 - €2.43
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€89.34M
Enterprise Value€1.04B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)16.5
Beta0.37
Next Earnings
Aug 15, 2025EPS EstimateN/A
Next Dividend Ex-Date
Jun 04, 2025Dividend Yield4.25%
Share Statistics
EPS (TTM)0.12
Shares Outstanding44,344,593
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.46
Price to Book (P/B)N/A
Price to Sales (P/S)3.43
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Vistin Pharma ASA News
PremiumCompany Announcements
Vistin Pharma ASA Releases Stable 2024 Annual Report
PremiumCompany Announcements
Vistin Pharma Reports Strong Q1 2025 Financial Results and Proposes DividendPremiumCompany Announcements
Vistin Pharma to Announce Q1 Results with Conference Call
PremiumCompany Announcements
Vistin Pharma ASA Reports Strong EBITDA Growth and Plans Dividend ProposalPremiumCompany Announcements
Vistin Pharma ASA to Announce Q4 and Preliminary 2024 Results
PremiumCompany Announcements
Vistin Pharma Reports Strong EBITDA and Dividend for Q3 2024
PremiumCompany Announcements
Saga Pure ASA Boosts Stake in Vistin Pharma---
VP4 FAQ
What was Vistin Pharma ASA’s price range in the past 12 months?
Vistin Pharma ASA lowest stock price was €1.72 and its highest was €2.43 in the past 12 months.
What is Vistin Pharma ASA’s market cap?
Vistin Pharma ASA’s market cap is €89.34M.
When is Vistin Pharma ASA’s upcoming earnings report date?
Vistin Pharma ASA’s upcoming earnings report date is Aug 15, 2025 which is in 110 days.
How were Vistin Pharma ASA’s earnings last quarter?
Vistin Pharma ASA released its earnings results on Apr 25, 2025. The company reported €0.041 earnings per share for the quarter, beating the consensus estimate of N/A by €0.041.
Is Vistin Pharma ASA overvalued?
According to Wall Street analysts Vistin Pharma ASA’s price is currently Overvalued.
Does Vistin Pharma ASA pay dividends?
Vistin Pharma ASA pays a Semiannually dividend of €0.105 which represents an annual dividend yield of 4.25%. See more information on Vistin Pharma ASA dividends here
What is Vistin Pharma ASA’s EPS estimate?
Vistin Pharma ASA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vistin Pharma ASA have?
Vistin Pharma ASA has 44,344,593 shares outstanding.
What happened to Vistin Pharma ASA’s price movement after its last earnings report?
Vistin Pharma ASA reported an EPS of €0.041 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.498%.
Which hedge fund is a major shareholder of Vistin Pharma ASA?
Currently, no hedge funds are holding shares in DE:VP4
---
Company Description
Vistin Pharma ASA
Vistin Pharma ASA is a Norway based pharmaceutical company. It is principally engaged in the business activity of producing active pharmaceutical ingredients (APIs) and solid dosage forms for the pharmaceutical industry. The company has two business segments namely Pharmaceuticals and Energy Trading. The group has operations in Norway, Germany, Switzerland, Great Britain, Algeria and other countries.
---
Technical Analysis
---